Stay updated on Nivolumab for Peripheral T-cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The website has added new features, while several detailed data fields and options for downloading study information have been removed.
    Difference
    6%
    Check dated 2024-11-23T06:01:02.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    New entries for Dendritic Cell Tumor and Blastic Plasmacytoid Dendritic Cell have been added, while numerous links related to various lymphomas and genetic conditions have been removed.
    Difference
    1%
    Check dated 2024-11-16T01:39:02.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The website has been updated to include numerous new links related to genetics and various lymphomas, as well as a new version revision (v2.12.2), replacing the previous version (v2.12.1).
    Difference
    4%
    Check dated 2024-11-08T19:09:14.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.4%
    Check dated 2024-11-01T11:39:40.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.
    Difference
    0.9%
    Check dated 2024-10-25T01:25:10.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-10-10T14:45:29.000Z thumbnail image

Stay in the know with updates to Nivolumab for Peripheral T-cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page.